Insulin and dexamethasone inhibit TGF-β-induced apoptosis of hepatoma cells upstream of the caspase activation cascade
Authors:
- Michael SchwarzMSMichael Schwarz
- Albrecht BuchmannABAlbrecht Buchmann
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 204 (2-3) , 141-154
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatmentAnti-Cancer Drugs, 2003
- The IGF‐1 receptor in cancer biologyInternational Journal of Cancer, 2003
- Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasoneCell Death & Differentiation, 2002
- Cellular Mechanisms for the Repression of ApoptosisAnnual Review of Pharmacology and Toxicology, 2002
- Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathwayCurrent Opinion in Neurobiology, 2001
- Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL inductionCell Death & Differentiation, 2001
- Liver toxicity and apoptosis: role of TGF-β1, cytochrome c and the apoptosomeToxicology Letters, 2001
- Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cellsCarcinogenesis, 2001
- Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activityCell Death & Differentiation, 1999
- Cell death by apoptosis and its protective role against diseaseTrends in Pharmacological Sciences, 1992